Alcor’s Scientific Advisory Board held its first meeting in Florida during December. A topic of discussion was the ongoing projects at Alcor and management’s plans for continuing development. Ralph Merkle and Robert Freitas also presented their plans for developing the medical nanotechnology that may be necessary to revive patients cryopreserved using current methods.
The point of the meeting was to establish how the advisory board could become more active in promoting cryonics and how the credibility of the field could be improved. Overall, it was an excellent meeting. The medical nanotechnology aspects of the meeting will be discussed in an upcoming issue of Cryonics magazine, and the advisory board intends to discuss other issues in more depth.
